Search for: "Patently Yours" Results 4941 - 4960 of 15,316
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Apr 2011, 9:11 pm by Vincent LoTempio
Well that's tricky because without a patent there is no IP and nothing is stopping the competition from copying your products. [read post]
1 Oct 2020, 5:21 am by Rose Hughes
However, the PEB also note that "Covid-19 restrictions mean that the CIPA/PEB office will not be fully staffed and there may be a delay in dealing with your call". [read post]
23 Feb 2011, 12:04 pm by Jonathan
A good starting off point is searching the United States Patent and Trademark Office’s TESS database for conflicting marks. [read post]
14 Dec 2009, 2:14 pm by admin
BlawgIT warns attorneys/firms: protect your websites and networks – for your sake and your client’s. [read post]
15 Nov 2007, 8:38 am
Absent that - it likely wouldn't matter what your background or expertise. [read post]
19 Jan 2008, 1:37 am
An InfoWorld piece, provocatively titled Microsoft 'spyware' to jack into your brain waves notes:According to a report in The Times, the patent, which was last month published by the U.S. [read post]
Key Discussion Points: Identifying and Securing IP Protection: Learn about the differences between trademark, trade dress, copyright, patent, and trade secret protection, and how to determine which laws will best protect your company’s key intangible assets. [read post]
1 Oct 2013, 2:59 am
So far, it has not been possible to confirm the rumour that, in keeping with the ethos of this new name, judges presiding over the rebranded tribunal are to be designated by a special new title or that they are to be addressed as "Your Efficiency" in place of the somewhat stuffy "Your Honour". [read post]
3 Jun 2024, 10:17 pm by Eleonora Rosati
Represented companies include, amongst others: Bayer, Haleon, Polpharma, Novo Nordisk, Amgen, Fresenius Kabi, Regeneron, and Sandoz.According to the organizers, the 2024 edition’s highlights include:A review of the latest decisions regarding the SPC waiver and its impact upon your generic and innovator life science exclusivity strategy.The intersection between regulatory and IP law with industry-led sessions on: clinical trials, data exclusivity, a Tecfidera case law review and the… [read post]
4 Nov 2010, 4:30 am by Gene Quinn
It is, therefore, critically important that the description of the business method be as complete as possible at the time of the filing of your first patent application, which means that the description must clearly identify the invention as of day one, even if you file a provisional patent application. [read post]
1 Jan 2017, 11:22 pm by Florian Mueller
Apple already tried to turn the Supreme Court hearing into the latter, which was legitimate: it's this old story of "if the facts are not on your side, argue the law; if the law is not on your side, argue policy", and here, if neither policy nor the law nor the facts are on your side, you (Apple) might still prevail on a procedural basis by harping on the record. [read post]
19 Jan 2011, 11:15 am by Gene Quinn
  I did not accept your case and told you, in fact, that I did not accept your case and would not represent you. [read post]
4 May 2016, 6:30 am
  IPRs are proceedings before the Patent Trial and Appeal Board Patent Trial and Appeal Board (PTAB) used to challenge issued patents, for example for obviousness. [read post]